Maricel Apuli - Mar 19, 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: Chief Accounting Officer
Signature: /s/ Maricel Apuli
Stock symbol: BBIO
Transactions as of: Mar 19, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/21/2025, 06:03 PM
Previous filing: Feb 27, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Award	$0	+23.7K	+18.93%	$0.00	149K	Mar 19, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Content

Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.